Internal Medicine, Hematology & Oncology · New Hyde Park, NY
NPI
1710949862
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1 Delaware Dr Ste 105
New Hyde Park, NY, 11042
Phone (516) 336-5255
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
91,897 services
Medicare patients, 2024
678
Average age 76
Drug cost, 2024
$10.0M
1,997 prescriptions
Company payments, 2025
$48K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarun Wasil was code J1439 (injection, ferric carboxymaltose, 1 mg), 27,000 times for 31 patients. In total Tarun Wasil billed 91,897 services in 193 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 27,000 | 31 | $0.87 | $23K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 5,400 | 18 | $44.71 | $241K |
| 88185 Surgical Pathology Examination | Office | 2,677 | 104 | $22.21 | $59K |
| J0897 Injection, denosumab, 1 mg | Office | 2,220 | 20 | $20.84 | $46K |
| 36415 Venipuncture Blood Collection | Office | 1,952 | 597 | $8.64 | $17K |
| 85025 Blood Count | Office | 1,900 | 573 | $7.61 | $14K |
| 80053 Clinical Chemistry | Office | 1,474 | 491 | $10.35 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,308 | 60 | $0.09 | $115 |
| 83735 Clinical Chemistry | Office | 1,227 | 422 | $6.57 | $8,061 |
| 83615 Clinical Chemistry | Office | 1,109 | 423 | $5.92 | $6,565 |
| 84550 Clinical Chemistry | Office | 1,004 | 404 | $4.43 | $4,448 |
| 99214 Office E&M - Established | Office | 1,001 | 341 | $108.51 | $109K |
| 84100 Clinical Chemistry | Office | 998 | 415 | $4.65 | $4,641 |
| 82728 Clinical Chemistry | Office | 845 | 334 | $13.36 | $11K |
| 83540 Clinical Chemistry | Office | 844 | 333 | $6.34 | $5,351 |
By year: 2022 $946K for 36,393 services; 2023 $1.4M for 72,850 services; 2024 $1.7M for 91,897 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 2,677 | 104 | $22.21 | $59K |
| 36415 Venipuncture Blood Collection | 1,952 | 597 | $8.64 | $17K |
| 85025 Blood Count | 1,900 | 573 | $7.61 | $14K |
| 80053 Clinical Chemistry | 1,474 | 491 | $10.35 | $15K |
| 83735 Clinical Chemistry | 1,227 | 422 | $6.57 | $8,061 |
| 83615 Clinical Chemistry | 1,109 | 423 | $5.92 | $6,565 |
| 84550 Clinical Chemistry | 1,004 | 404 | $4.43 | $4,448 |
| 84100 Clinical Chemistry | 998 | 415 | $4.65 | $4,641 |
| 82728 Clinical Chemistry | 845 | 334 | $13.36 | $11K |
| 83540 Clinical Chemistry | 844 | 333 | $6.34 | $5,351 |
Medicare prescription drug claims, 2024
In 2024, the drug Tarun Wasil prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 125 prescriptions and refills. In total Tarun Wasil wrote 1,997 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 125 | 129 | 24 | $519K |
| Akynzeo Fosnetupitant/Palonosetron | 117 | 117 | 28 | $158K |
| Procrit Epoetin Alfa | 101 | 103 | 19 | $174K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 88 | 88 | Under 11 | $435K |
| Anastrozole Generic | 73 | 157 | 24 | $918 |
| Xgeva Denosumab | 55 | 55 | Under 11 | $160K |
| Eliquis Apixaban | 55 | 69 | 15 | $40K |
| Ondansetron Odt Ondansetron | 51 | 51 | 32 | $741 |
| Acyclovir Generic | 49 | 98 | 12 | $487 |
| Prednisone Generic | 47 | 51 | 11 | $255 |
| Allopurinol Generic | 47 | 96 | 19 | $263 |
| Revlimid Lenalidomide | 46 | 46 | Under 11 | $826K |
| Calquence Acalabrutinib Maleate | 45 | 45 | Under 11 | $682K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 42 | 43 | Under 11 | $653K |
| Abiraterone Acetate Generic | 42 | 42 | Under 11 | $125K |
Brand drugs: 1,217 claims; generic drugs: 780 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarun Wasil $48K ($48K in general payments such as food, travel and fees) from 10 companies. The largest payer was GlaxoSmithKline, LLC. with $17K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 15 | $17K |
| Lilly USA, LLC LLY | 6 | $9,083 |
| Pfizer Inc. PFE | 5 | $5,207 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $5,019 |
| Genzyme Corporation SNY | 3 | $3,100 |
| Abbvie Inc. ABBV | 2 | $2,550 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $2,467 |
| Janssen Biotech, Inc. JNJ | 1 | $1,645 |
| B. Braun Medical Inc. | 1 | $1,156 |
| Incyte Corporation INCY | 1 | $860 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.